2011
DOI: 10.1007/s12035-011-8202-4
|View full text |Cite
|
Sign up to set email alerts
|

Genes and Pathways Co-associated with the Exposure to Multiple Drugs of Abuse, Including Alcohol, Amphetamine/Methamphetamine, Cocaine, Marijuana, Morphine, and/or Nicotine: a Review of Proteomics Analyses

Abstract: Drug addiction is a chronic neuronal disease. In recent years, proteomics technology has been widely used to assess the protein expression in the brain tissues of both animals and humans exposed to addictive drugs. Through this approach, a large number of proteins potentially involved in the etiology of drug addictions have been identified, which provide a valuable resource to study protein function, biochemical pathways, and networks related to the molecular mechanisms underlying drug dependence. In this arti… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

3
79
0

Year Published

2013
2013
2019
2019

Publication Types

Select...
5
3

Relationship

0
8

Authors

Journals

citations
Cited by 85 publications
(82 citation statements)
references
References 118 publications
(163 reference statements)
3
79
0
Order By: Relevance
“…Nevertheless, owing to the limitations of the methods utilized to date, not all the proteins associated with alcohol exposure have been identified by proteomic technologies. Similar to what has been found for other proteomic studies of addictive disorders (Wang et al, 2011), the majority of identified proteins related to alcohol abuse belong to a relatively small number of functional categories (Figure 1). This is consistent with the observation that some genetic influences may not be specific for alcohol-use disorders, but likely reflect a general vulnerability for polysubstance abuse (Gorini et al, 2011;Mayfield et al, 2008;Nestler, 2005).…”
Section: Proteins and Pathways Associated With Alcohol Exposuresupporting
confidence: 85%
See 2 more Smart Citations
“…Nevertheless, owing to the limitations of the methods utilized to date, not all the proteins associated with alcohol exposure have been identified by proteomic technologies. Similar to what has been found for other proteomic studies of addictive disorders (Wang et al, 2011), the majority of identified proteins related to alcohol abuse belong to a relatively small number of functional categories (Figure 1). This is consistent with the observation that some genetic influences may not be specific for alcohol-use disorders, but likely reflect a general vulnerability for polysubstance abuse (Gorini et al, 2011;Mayfield et al, 2008;Nestler, 2005).…”
Section: Proteins and Pathways Associated With Alcohol Exposuresupporting
confidence: 85%
“…Although the methodologies are continuously evolving, proteomic strategies have already become essential tools for elucidating the molecular effects of addictive substances. In the past decade, the number of laboratories using protein expression profiling to define changes in global proteomes in cultured neurons or different brain regions of animals or humans in response to substances of abuse has been steadily growing (Bierczynska-Krzysik et al, 2006;Hemby and Tannu, 2009;Hemby, 2010;Li and Wang, 2007;Romanova et al, 2012;Song et al, 2012;Wang et al, 2011;Witzmann and Strother, 2004).…”
Section: Fda-approved Medications For the Treatment Audsmentioning
confidence: 99%
See 1 more Smart Citation
“…As reported by numerous studies, some cell signaling cascades are activated by METH and cocaine, such as the ERK, phosphatidylinositol 3-kinase, V-akt murine thymoma viral oncogene homolog 1 (Akt-1), and CREB pathways. The transcription factor CREB is often induced after chronic abuse of drugs (4245). …”
Section: Introductionmentioning
confidence: 99%
“…45 Finally, neuroscientists have begun using proteomics technologies evaluating brain tissue in the context of illicit drug use to demonstrate that cannabis use is associated with oxidative stress and alterations in signal transduction. 46 However, use of proteomics and other omics technologies to establish mechanistic eff ects of cannabis on lung remain virtually unexplored.…”
Section: Expanding Preclinical Investigations Using Novel Technologiesmentioning
confidence: 99%